Protective role of Bruton tyrosine kinase inhibitors in patients with chronic lymphocytic leukaemia and COVID-19

Santiago Thibaud, Douglas Tremblay, Sheena Bhalla, Brittney Zimmerman, Keith Sigel, Janice Gabrilove

Research output: Contribution to journalLetterpeer-review

63 Scopus citations
Original languageEnglish
Pages (from-to)e73-e76
JournalBritish Journal of Haematology
Volume190
Issue number2
DOIs
StatePublished - 1 Jul 2020

Keywords

  • BTK inhibitors
  • CLL
  • COVID-19

Cite this